İnan Güden, Irem Karatas, Yalın Iscan, Gulcin Yegen, Semen Onder, Nihat Aksakal, Fatih Tunca, Yasemin Giles Senyurek, Ismail Cem Sormaz
{"title":"甲状腺结节性甲状腺肿与格雷夫斯病分化型甲状腺癌临床及病理特征比较","authors":"İnan Güden, Irem Karatas, Yalın Iscan, Gulcin Yegen, Semen Onder, Nihat Aksakal, Fatih Tunca, Yasemin Giles Senyurek, Ismail Cem Sormaz","doi":"10.1530/EC-25-0183","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Graves' disease (GD) is characterized by autoimmune hyperthyroidism. Its association with papillary thyroid carcinoma (PTC) remains controversial, with conflicting data regarding tumor aggressiveness and clinical outcomes.</p><p><strong>Objective: </strong>To compare the clinical and histopathological features of PTC in patients with GD versus those with euthyroid nodular goiter.</p><p><strong>Methods: </strong>A retrospective review was conducted on 995 patients who underwent thyroidectomy for PTC between 2014 and 2023. Group 1 included 59 patients with GD and coexisting PTC, while group 2 comprised 936 euthyroid patients with PTC. Tumor characteristics, recurrence rates, and treatment outcomes were analyzed.</p><p><strong>Results: </strong>PTCs in the GD group were more frequently papillary microcarcinomas (85 vs 43%, P < 0.001) and exhibited significantly lower rates of multicentricity, vascular invasion, and lymph node metastasis. There were no statistically significant differences in recurrence or distant metastasis between groups. Multivariate analysis identified older age and the presence of thyroid nodules as independent predictors of PTC in patients with GD.</p><p><strong>Conclusion: </strong>PTC associated with GD appears to exhibit more favorable histopathological features. However, the risk of malignancy increases with age and ultrasonographically detected nodules in GD patients. These findings support the importance of vigilant surveillance and individualized treatment planning in this population.</p>","PeriodicalId":11634,"journal":{"name":"Endocrine Connections","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12492166/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of clinical and histopathological characteristics of differentiated thyroid cancers in euthyroid nodular goiter and Graves' disease.\",\"authors\":\"İnan Güden, Irem Karatas, Yalın Iscan, Gulcin Yegen, Semen Onder, Nihat Aksakal, Fatih Tunca, Yasemin Giles Senyurek, Ismail Cem Sormaz\",\"doi\":\"10.1530/EC-25-0183\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Graves' disease (GD) is characterized by autoimmune hyperthyroidism. Its association with papillary thyroid carcinoma (PTC) remains controversial, with conflicting data regarding tumor aggressiveness and clinical outcomes.</p><p><strong>Objective: </strong>To compare the clinical and histopathological features of PTC in patients with GD versus those with euthyroid nodular goiter.</p><p><strong>Methods: </strong>A retrospective review was conducted on 995 patients who underwent thyroidectomy for PTC between 2014 and 2023. Group 1 included 59 patients with GD and coexisting PTC, while group 2 comprised 936 euthyroid patients with PTC. Tumor characteristics, recurrence rates, and treatment outcomes were analyzed.</p><p><strong>Results: </strong>PTCs in the GD group were more frequently papillary microcarcinomas (85 vs 43%, P < 0.001) and exhibited significantly lower rates of multicentricity, vascular invasion, and lymph node metastasis. There were no statistically significant differences in recurrence or distant metastasis between groups. Multivariate analysis identified older age and the presence of thyroid nodules as independent predictors of PTC in patients with GD.</p><p><strong>Conclusion: </strong>PTC associated with GD appears to exhibit more favorable histopathological features. However, the risk of malignancy increases with age and ultrasonographically detected nodules in GD patients. These findings support the importance of vigilant surveillance and individualized treatment planning in this population.</p>\",\"PeriodicalId\":11634,\"journal\":{\"name\":\"Endocrine Connections\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12492166/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Connections\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1530/EC-25-0183\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Connections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/EC-25-0183","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:Graves病(GD)以自身免疫性甲状腺功能亢进为特征。它与甲状腺乳头状癌(PTC)的关系仍然存在争议,关于肿瘤侵袭性和临床结果的数据相互矛盾。目的:比较GD患者与甲状腺功能正常的结节性甲状腺肿患者PTC的临床和组织病理学特征。方法:回顾性分析2014年至2023年995例甲状腺切除术患者的PTC。组1为GD合并PTC患者59例,组2为甲状腺功能正常合并PTC患者936例。分析肿瘤特征、复发率和治疗结果。结果:GD组ptc多为乳头状微癌(85% vs. 43%, p < 0.001),多中心性、血管侵犯和淋巴结转移率明显降低。两组间复发及远处转移无统计学差异。多因素分析发现,年龄和甲状腺结节的存在是GD患者PTC的独立预测因素。结论:PTC合并GD表现出更有利的组织病理学特征。然而,随着年龄的增长和超声检查发现GD患者的结节,恶性肿瘤的风险增加。这些发现支持了警惕监测和个体化治疗计划在这一人群中的重要性。
Comparison of clinical and histopathological characteristics of differentiated thyroid cancers in euthyroid nodular goiter and Graves' disease.
Background: Graves' disease (GD) is characterized by autoimmune hyperthyroidism. Its association with papillary thyroid carcinoma (PTC) remains controversial, with conflicting data regarding tumor aggressiveness and clinical outcomes.
Objective: To compare the clinical and histopathological features of PTC in patients with GD versus those with euthyroid nodular goiter.
Methods: A retrospective review was conducted on 995 patients who underwent thyroidectomy for PTC between 2014 and 2023. Group 1 included 59 patients with GD and coexisting PTC, while group 2 comprised 936 euthyroid patients with PTC. Tumor characteristics, recurrence rates, and treatment outcomes were analyzed.
Results: PTCs in the GD group were more frequently papillary microcarcinomas (85 vs 43%, P < 0.001) and exhibited significantly lower rates of multicentricity, vascular invasion, and lymph node metastasis. There were no statistically significant differences in recurrence or distant metastasis between groups. Multivariate analysis identified older age and the presence of thyroid nodules as independent predictors of PTC in patients with GD.
Conclusion: PTC associated with GD appears to exhibit more favorable histopathological features. However, the risk of malignancy increases with age and ultrasonographically detected nodules in GD patients. These findings support the importance of vigilant surveillance and individualized treatment planning in this population.
期刊介绍:
Endocrine Connections publishes original quality research and reviews in all areas of endocrinology, including papers that deal with non-classical tissues as source or targets of hormones and endocrine papers that have relevance to endocrine-related and intersecting disciplines and the wider biomedical community.